Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-020043
Filing Date
2023-03-20
Accepted
2023-03-20 16:26:33
Documents
1
Period of Report
2023-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5686
  Complete submission text file 0001209191-23-020043.txt   7035
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
Sanna Bastiano (Reporting) CIK: 0001829069 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 23746648